chr11-62605653-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_153265.3(EML3):āc.1903A>Cā(p.Ile635Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000848 in 1,545,232 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_153265.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EML3 | NM_153265.3 | c.1903A>C | p.Ile635Leu | missense_variant | 15/22 | ENST00000394773.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EML3 | ENST00000394773.7 | c.1903A>C | p.Ile635Leu | missense_variant | 15/22 | 1 | NM_153265.3 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152114Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000254 AC: 5AN: 196948Hom.: 0 AF XY: 0.0000288 AC XY: 3AN XY: 104314
GnomAD4 exome AF: 0.0000883 AC: 123AN: 1393118Hom.: 0 Cov.: 31 AF XY: 0.0000977 AC XY: 67AN XY: 685890
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152114Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74306
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 13, 2023 | The c.1903A>C (p.I635L) alteration is located in exon 15 (coding exon 15) of the EML3 gene. This alteration results from a A to C substitution at nucleotide position 1903, causing the isoleucine (I) at amino acid position 635 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at